SOLESENCE, INC. 8-K

What Happened

• On July 6, 2026, Solésence, LLC (a wholly owned subsidiary of Solésence, Inc.) entered into a Settlement Agreement and Release with Refy Beauty Ltd to resolve disputes over certain consumer care products previously sold to Refy.
• Under the agreement Solésence agreed to pay Refy the British pound sterling equivalent of $938,000 in twelve equal installments of $78,166.66, with the first installment due August 5, 2026 and each subsequent payment due every 30 days. The parties also agreed to a six‑month exclusivity period to develop a new SPF product and may negotiate a new supply agreement for that product.

Key Details

• Agreement date: July 6, 2026 (Settlement Agreement and Release).
• Payment amount: British pound sterling equivalent of $938,000, paid in 12 equal installments of $78,166.66.
• Payment schedule: First payment due August 5, 2026; then every 30 days thereafter.
• Exclusivity & potential offset: Six‑month exclusivity for developing a new SPF product; if a supply agreement is reached, the final six scheduled installment payments would be credited toward purchase of the SPF product.
• Document filed: Settlement Agreement is attached as an exhibit to the 8‑K with confidential portions redacted.

Why It Matters

• This settlement creates a specified cash obligation (approximately $938k total) with near‑term monthly outflows starting in August 2026, which can affect Solésence’s cash flow and liquidity planning.
• The six‑month exclusivity and potential supply agreement could convert some of the settlement payments into product purchases, which may lead to future revenue or ongoing commercial relationship with Refy if a deal is reached.
• For investors, the filing reduces legal uncertainty related to the dispute and provides clear terms and timing of the cash impact; monitor future filings for any supply agreement or additional financial disclosures.